Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS.
Utilizing an enzyme-linked immunosorbent assay, we detected elevated serum levels of soluble interleukin 2 receptors (SIL-2R) in 73% of patients with acquired immunodeficiency syndrome (AIDS), 80% of AIDS-related complex patients, 78% of anti-HIV-positive lymphadenopathy syndrome patients, 85% of HIV-antibody-positive hemophiliacs, and 80% of anti-HIV-positive asymptomatic homosexual males, iv drug abusers, and heterosexual contacts. Of the subjects with no demonstrable antibody to HIV, 29% of hemophiliacs, 12% of adult homosexual males and iv drug abusers, and none of the patients with lymphadenopathy had elevated SIL-2R. Overall, only 5 of 40 antibody-negative "high-risk" individuals had SIL-2R values greater than the reference interval whereas 108 of 138 antibody-positive individuals had elevated values (chi 2 = 57.85, P less than 0.001).
D000386:AIDS-Related Complex / Q000378:metabolism*; D000163:Acquired Immunodeficiency Syndrome / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006679:HIV Seropositivity / Q000378:metabolism*; D006467:Hemophilia A / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007223:Infant; D008297:Male; D011971:Receptors, Immunologic / Q000378:metabolism*; D015375:Receptors, Interleukin-2; D012307:Risk Factors
D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2